COLUSSI, Gian Luca
 Distribuzione geografica
Continente #
NA - Nord America 10.214
EU - Europa 3.503
AS - Asia 1.288
SA - Sud America 150
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 12
OC - Oceania 4
Totale 15.191
Nazione #
US - Stati Uniti d'America 10.156
UA - Ucraina 1.113
IT - Italia 788
SG - Singapore 546
CN - Cina 491
DE - Germania 484
FI - Finlandia 363
RU - Federazione Russa 266
IE - Irlanda 195
BR - Brasile 139
TR - Turchia 113
SE - Svezia 110
CA - Canada 49
VN - Vietnam 48
GB - Regno Unito 44
FR - Francia 40
BE - Belgio 23
EU - Europa 19
AT - Austria 18
IR - Iran 16
CZ - Repubblica Ceca 14
IN - India 13
KR - Corea 11
NL - Olanda 10
HK - Hong Kong 9
BD - Bangladesh 7
MX - Messico 6
JP - Giappone 5
AR - Argentina 4
EE - Estonia 4
IQ - Iraq 4
PL - Polonia 4
AU - Australia 3
CH - Svizzera 3
CO - Colombia 3
DK - Danimarca 3
EG - Egitto 3
PK - Pakistan 3
RO - Romania 3
TG - Togo 3
AM - Armenia 2
AZ - Azerbaigian 2
BT - Bhutan 2
JO - Giordania 2
LK - Sri Lanka 2
LT - Lituania 2
LV - Lettonia 2
MA - Marocco 2
ME - Montenegro 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ES - Italia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
TN - Tunisia 1
Totale 15.191
Città #
Woodbridge 1.428
Fairfield 1.110
Ann Arbor 912
Jacksonville 795
Chandler 594
Houston 573
Ashburn 532
Dearborn 501
Wilmington 494
Seattle 452
Cambridge 370
Boardman 282
Singapore 257
Princeton 217
Dublin 193
Beijing 180
Udine 148
Izmir 107
San Diego 83
Des Moines 48
Ogden 48
Dong Ket 47
Hefei 44
Norwalk 44
Redmond 42
Ottawa 39
Milan 37
Nanjing 37
Rome 32
San Mateo 32
Kunming 30
Guangzhou 25
Helsinki 24
Brussels 23
Nuremberg 22
Los Angeles 20
Trieste 19
Munich 15
Shanghai 14
Mcallen 13
Vienna 13
Brno 12
Grafing 12
Falls Church 11
Washington 11
Jinan 10
Bologna 9
Fuzhou 9
Hong Kong 9
Pignone 9
Turin 9
Vicenza 9
Council Bluffs 8
Espoo 8
Indiana 8
New York 8
Phoenix 8
Wuhan 8
Ferrara 7
Santa Clara 7
São Paulo 7
Hangzhou 6
Hebei 6
Leawood 6
Nanchang 6
Tavagnacco 6
Torre Del Greco 6
Zhengzhou 6
Ancona 5
Castellammare Di Stabia 5
Changsha 5
Henderson 5
London 5
Mumbai 5
Palermo 5
Paris 5
Rio de Janeiro 5
Saint Petersburg 5
Simi Valley 5
Toronto 5
Venezia 5
Venice 5
Verona 5
Xian 5
Zanjan 5
Andover 4
Baghdad 4
Bari 4
Belo Horizonte 4
Fontanafredda 4
Lanzhou 4
Mascali 4
Nanning 4
Naples 4
San Giuseppe Vesuviano 4
Shenyang 4
Taizhou 4
Tallinn 4
West Jordan 4
Winnipeg 4
Totale 10.262
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 241
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 165
Aldosterone and the heart: from basic research to clinical evidence 153
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 151
Aldosterone and Left Ventricular Remodeling 143
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 141
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 133
Aldosterone and the heart: still an unresolved issue? 130
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 130
Aldosterone, Organ Damage, and Dietary Salt 128
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 126
The emergent cardiovascular risk factors and organ damage in arterial hypertension 124
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 124
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 124
Treatment of primary aldosteronism and organ protection 123
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 122
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 122
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 122
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 121
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 119
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 118
Benzodiazepines: an old class of new antihypertensive drugs? 117
Kidney in primary aldosteronism: a key determinant of treatment outcome 116
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 116
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 115
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 114
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 114
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 112
Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron 112
Salt, hypertension, and cardiovascular disease 111
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 110
Cardiovascular outcomes in patients with primary aldosteronism after treatment 110
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 109
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 109
Potassium-sparing diuretics in hypertension 108
Renal function in primary aldosteronism 107
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 106
Diabetes, diabetic complications, and blood pressure targets 106
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 105
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 105
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good? 105
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 105
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 104
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 104
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 103
Hypertension and type 2 diabetes: lights and shadows about causality 102
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients 99
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 99
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 98
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 98
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 97
Uricaemia and left ventricular mass in hypertensive patients 97
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 97
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 96
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 95
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 95
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 95
Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients 95
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 93
Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era 93
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients: Response to Perciaccante et al. [4] 93
Response to "plasma Homocysteine Levels and Endothelial Dysfunction in Cerebro-and Cardiovascular Diseases in the Metabolic Syndrome" 93
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients 93
Associazione dell’ispessimento miointimale carotideo con uno stato protrombotico in pazienti ipertesi 92
Plasma lipoprotein(a) levels and atherosclerotic renal artery stenosis in hypertensive patients 92
Aldosterone plasmatico e escrezione urinaria di albumina nell’ipertensione arteriosa 90
Omega-3 polyunsaturated fatty acids in blood pressure control and essential hypertension 90
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 90
Relationships of plasma renin with renal function in primary aldosteronism: revisiting the concept of renin escape 89
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 87
Association of elevated levels of PAI-1 with insulin resistance and inflammatory markers in hypertension. 85
Hyperaldosteronism and Left Ventricular Hypertrophy 85
Studio della funzione endoteliale in pazienti con steatosi epatica non-alcolica. 83
Alpha-adducin gene polymorphism predicts cardiac and vascular response to treatment in hypertensive women 82
Mineralocorticoid Antagonists Treatment Versus Surgery in Primary Aldosteronism 82
The carotid intima-media thickness and cardiac tissue Doppler in hypertension 81
Effects of n-3 polyunsatured fatty acids (PUFA) on markers of oxidative stress in hypertension 81
Ambulatory blood pressure and left ventricular geometry in patients with myotonic dystrophy 81
Functioning or Non-Functioning Adrenal Adenoma? Probably, Just a Matter of Time 80
Evaluation of endothelial function in patients with non-alcoholic fatty liver disease 79
Novel role for SGK3 in glucose homeostasis revealed in SGK3/Akt2 double-null mice 79
Effects of renal revascularization on renal and cardiac function in hypertensive patients 78
Association of a prothrombotic state with carotid intima-media thickness in hypertensive patients 78
The new cardiovascular risk factors in hypertensive patients with metabolic syndrome 78
Predictive factors of left ventricular mass changes after treatment of primary aldosteronism 76
Metabolic Dysfunction in Primary Aldosteronism 76
ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature 74
Ipertensione arteriosa e poliglobulia in paziente con stenosi multiple delle arterie renali 73
Association of a prothrombotic state with the metabolic syndrome in essential hypertensive patients 72
Plasma aldosterone levels are related to urinary albumin excretion in hypertensive patients 71
Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study 71
ACIDI GRASSI POLIINSATURI OMEGA-3 E FATTORI DI RISCHIO CARDIOVASCOLARE 71
Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma 70
Endothelial function in patients with non-alcoholic fatty liver disease 70
null 70
Aldosterone and aldosterone antagonists in cardiac disease: what is known, what is new 69
Left ventricular dysfunction and the intima-media thickness: a Tissue-Doppler study 68
La lipoproteina(a) come fattore di rischio cardiovascolare: una revisione delle conoscenze attuali 67
Effects of omega-3 PUFA on plasma lipoprotein(a) in hypertensive patients 67
Insulin resistance in the early stages of renal failure: implication for cardiovascular risk 67
Totale 10.105
Categoria #
all - tutte 64.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020883 0 0 0 0 0 0 0 0 238 303 66 276
2020/20212.441 69 243 68 315 79 333 136 278 411 81 292 136
2021/20221.596 76 182 64 125 47 55 85 96 22 256 307 281
2022/20231.649 251 95 31 184 139 486 6 92 234 24 55 52
2023/2024520 91 32 41 9 82 58 23 12 70 20 8 74
2024/20251.559 80 265 141 116 72 155 173 186 371 0 0 0
Totale 15.774